Katie Thurston reveals her HER2-negative breast cancer is treated with hormone therapy instead of chemo, detailing her custom treatment plan.

Thousands with advanced breast cancer could live long lives thanks to a new drug approved on the NHS . Capivasertib, retailed ...

Bria-IMT plus check point inhibitors had a median overall survival which outperformed that of antibody-drug conjugates in HR+ ...

The Coordinator of the National Cancer Control Programme, Ministry of Health and Social Welfare, Dr Uche Nwokwu, has said ...

The National Institute for Health and Care Excellence has now approved capivasertib for use on the NHS - we look at who could ...

The National Institute for Health and Care Excellence (NICE) has approved the use of the tablet capivasertib, in combination ...

AstraZeneca’s Truqap (capivasertib) has been approved for use by the National Health Service (NHS) in England and Wales, ...

Professor Nicholas Turner, from the Institute of Cancer Research, tells Sky News that capivasertib is a "great success story ...

Even after the removal of breast tissue, it is possible that the cancer may recur in the chest wall or the area where the ...

Breast cancer subtyping is essential for determining appropriate treatment strategies, as each molecular category, luminal A, ...

A new type of drug for one of the most common kinds of advanced breast cancer is now available on the NHS in England. Some ...

During a live event, Megan Kruse, MD, discussed NCCN guidelines and key therapies for patients with HR-positive metastatic ...